12,000 diabetes records put kidney risk under the microscope
NCT ID NCT07818434
First seen Sep 14, 2026 · Last updated Sep 15, 2026 · Updated 1 time
Summary
Researchers are examining the medical records of 12,000 people with type 2 diabetes who visited a large diabetes care center in Southern India during 2022 and 2023. The study aims to estimate how many of these patients have kidney insufficiency, a complication that past estimates have placed at widely different levels. The team will also look at whether age, gender, body mass index, blood sugar control, and high blood pressure relate to kidney problems. This is a retrospective study, meaning it analyzes existing data rather than testing a treatment.
What this could mean
Our plain-language read of the trial. This is informational only, not medical advice or a prediction.
- What this could lead to
- If the study maps how common kidney insufficiency is in this group, it could help clinics in Southern India spot kidney problems earlier in people with type 2 diabetes.
- What could go wrong
- This study looks back at existing records from one diabetes center, so its numbers may not apply to other regions or health systems. It cannot prove what causes kidney insufficiency, only describe patterns.
This is an AI summary of the original study and may miss details. Read our disclaimer.
Study facts
What this study's own registry entry says, in plain language.
- Participants
-
12,000 people
The number who actually took part.
- Started
-
Feb 2022
- Finished
-
May 2024
- Lead sponsor
-
Other sponsor
The registry's catch-all category, for sponsors it does not file as a company, a government agency, or a research network.
Who can take part
This study's own entry requirements. Only the study team can say for certain whether you qualify.
Who is studied
Patients who had visited the Diabetes care centre during the study period.
- Ages
-
Children (under 18), adults (18 to 64) and older adults (65 and over)
- Sex
-
Anyone
- Healthy volunteers
-
Not accepted
This study is not open to healthy volunteers. The entry requirements below say who it is open to.
Show the full entry requirements Hide the full entry requirements
Copied word for word from the study's registry entry, so the wording is the study team's rather than ours.
Inclusion Criteria: Type 2 diabetes patients who attended the outpatient department of the hospital during 2022 and 2023 will be included in the study. Exclusion Criteria Type 1 Diabetes and other forms. .
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for Diabetic kidney disease are added.
By submitting, you agree to our Terms of use
Conditions
The condition(s) this trial relates to.
As listed by the trial registrant
The condition terms exactly as the trial's registrant entered them.
Contacts and locations
Locations
-
Dr.A.Ramachandrans'S Diabetes Hospitals
Chennai, Tamil Nadu, 600032, India
More trials for these conditions
Other studies related to the condition(s) this trial covers.
- New pill takes aim at stubborn blood sugar
- Gene therapy shots aim to save legs from amputation in diabetes
- New pill takes aim at blood sugar in diabetes
- Can AI-Tailored heat warnings shield chronic disease patients from dangerous temperatures?
- Can a Patient's own kidney cells hold off dialysis?
- Weekly shot aims to melt away pounds in obesity fight